BioSpace News Archive

RELIEF THERAPEUTICS Holding SA reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals, Inc., has issued a press release announcing an additional finding in its phase 2b/3 clinical trial investigating ZYESAMI for the treatment of patients with acute Respiratory Failure due to Critical COVID-19.

GenSight Biologics announced that the Journal of Neuro-Ophthalmology has published results from RESTORE, the long-term follow-up study of LUMEVOQ®, which show sustained treatment effect from a unilateral injection of LUMEVOQ® three years after injection in the RESCUE and REVERSE trials.

Elekta announced the presentation of 72 abstracts demonstrating the technical capabilities and clinical utility of the Elekta Unity MR-Linac.

Micropipette is a laboratory tool used to measure and transfer a small volume of solution.

Technological improvements in anesthesiology are well known. These techniques are primarily used to enhance the patient’s safety.

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics, reported its interim results for the six months ended June 30, 2021, and provided key business updates.

Hansa Biopharma to participate in several leading global healthcare conferences in September

Dr. Reddy’s Laboratories Ltd. announced the launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules USP, 5 mg/2.5 mg, a therapeutic equivalent generic version of Librax® approved by the U.S. Food and Drug Administration.

Medivir AB announced that the company has received regulatory approval from the British Medicines & Healthcare products Regulatory Agency for its upcoming phase 1/2a combination study with the company’s leading candidate drug MIV-818 against liver cancer.

Kodiak Sciences Inc. announced that management will present at the virtual Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021, at 8:45 a.m. Pacific Time.